Back
Artiva Biotherapeutics, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
67
ARTV
Artiva Biotherapeutics, Inc.
Last Price:
$3.69
Seasonality Move:
-1.06%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiArtiva Biotherapeutics, Inc. Stock Forecast
-
Is Artiva Biotherapeutics, Inc. Stock Undervalued?The current Artiva Biotherapeutics, Inc. [ARTV] share price is $3.78. The Score for ARTV is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
ARTV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Artiva Biotherapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Artiva Biotherapeutics, Inc. Stock Rating
Data Unavailable
Artiva Biotherapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
artivabio.com
52-Week Data
52-Week High:
13.14
52-Week Low:
1.47
Prediction Charts
Market Cap:
92M
Price in USD:
3.78
Volume:
62K
Beta:
3.31
Technical Analysis
SMA50:
3.59
SMA100:
3.21
SMA200:
2.96
52-Wk Change:
-70.32%
Stock Predictions
-
Is Artiva Biotherapeutics, Inc. stock public?Yes, Artiva Biotherapeutics, Inc. is a publicly traded company.
-
What is the Artiva Biotherapeutics, Inc. stock quote today?The Artiva Biotherapeutics, Inc. stock price is 3.78 USD today.
-
How to buy Artiva Biotherapeutics, Inc. stock online?You can buy Artiva Biotherapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 3.25 | 3.25 | 3.39 | 3.20 |
| Nov-17 | 3.25 | 3.51 | 3.54 | 3.19 |
| Nov-18 | 3.61 | 3.89 | 3.94 | 3.54 |
| Nov-19 | 3.92 | 3.39 | 3.92 | 3.34 |
| Nov-20 | 3.49 | 3.17 | 3.49 | 3.16 |
| Nov-21 | 3.10 | 3.13 | 3.34 | 3.05 |
| Nov-24 | 3.12 | 3.31 | 3.35 | 3.12 |
| Nov-25 | 3.34 | 3.37 | 3.40 | 3.21 |
| Nov-26 | 3.34 | 3.58 | 3.65 | 3.28 |
| Nov-28 | 3.62 | 3.76 | 3.78 | 3.58 |
| Dec-1 | 3.69 | 3.47 | 3.69 | 3.36 |
| Dec-2 | 3.53 | 3.34 | 3.53 | 3.30 |
| Dec-3 | 3.36 | 3.58 | 3.62 | 3.28 |
| Dec-4 | 3.55 | 3.78 | 3.79 | 3.51 |
Artiva Biotherapeutics, Inc. Earnings
Data Unavailable
Artiva Biotherapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.99 per share, and an increase next year of $0.52 per share.
* Artiva Biotherapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.